Skip to main content

Advertisement

SpringerLink
Log in

Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The clinical utility of standard liver function tests for monitoring low dose pulse methotrexate therapy is reviewed in 163 rheumatoid arthritis patients over an eightyear period. Abnormalities of hepatic enzymes were seen in 58% of patients but led to cessation of therapy in only 5%. Moderate alcohol intake did not affect the frequency of liver test abnormalities. Abnormalities were seen more frequently in patients with longer duration of methotrexate therapy and in those with higher total dose. There was no correlation between liver test abnormalities and day of serum sampling relative to day of methotrexate dosing, nor was a correlation seen between liver test abnormalities and total weekly dose of methotrexate. Methotrexate has been demonstrated to be an effective drug in the treatment of rheumatoid arthritis. The clinical utility of standard liver tests to predict the potential for hepatotoxicity is questionable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Willkens, R.F., Watson, M.A., Paxson, C.S. Low dose pulse methotrexate therapy in rheumatoid arthritis. J Rheumatol, 1980, 7, 501–505.

    CAS  PubMed  Google Scholar 

  2. Michaels, R.M., Nashel, D.J., Leonard, A., et al. Weekly intravenous methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum, 1982, 25, 339–341.

    CAS  PubMed  Google Scholar 

  3. Weinstein, A., Marlowe, S., Korn, J., et al. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations. Am J Med 1985, 79, 331–337.

    Article  CAS  PubMed  Google Scholar 

  4. Groff, G.D., Shenberger, K.N., Wilke, W.S., et al. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature. Semin Arthritis Rheum 1983, 12, 333–347.

    Article  CAS  PubMed  Google Scholar 

  5. Kremer, J.M., Lee, J.K.: The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum, 1986, 29, 822.

    CAS  PubMed  Google Scholar 

  6. Williams, H.J., Willkens, R.F., Samuelson, C.O.Jr., et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1985, 28, 721–730.

    CAS  PubMed  Google Scholar 

  7. Weinblatt, M.E., Coblyn, J.S., Fox, D.A., et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. New Engl J Med 1985, 312, 818–854.

    CAS  PubMed  Google Scholar 

  8. Anderson, P.A., West, S.G., O'Dell, J.R., et al. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med, 1985, 103, 489–496.

    Google Scholar 

  9. Farber, S. Temporary remissions in acute leukemia in chidren produced by folic acid antagonists, 4-aminopteroylglutamic acid (aminopterin). New Engl J Med, 1984, 56, 787–793.

    Google Scholar 

  10. Wetherley-Mein, G., Cottom, D.G. Portal fibrosis in acute leukemia. Br J Haematol, 1956, 2, 345–354.

    PubMed  Google Scholar 

  11. Colsky, J., Greenspan, E.M., Warren, T.N. Hepatic fibrosis in children with acute leukemia treated with folic acid antagonists. Arch Pathol 1955, 56, 198–206.

    Google Scholar 

  12. Ryan, T.J., Vickers, H.R., Salem, S.N., et al. The treatment of psoriasis with folic acid antagonists. Br J Dermatol, 1964, 76, 555–564.

    CAS  PubMed  Google Scholar 

  13. Reese, L.T., Grisham, J.W., Aach, R.D., et al. Effects of methotrexate on the liver in psoriasis. J Invest Dermatol, 1974, 62, 597–602.

    Article  CAS  PubMed  Google Scholar 

  14. Zachariae, H., Grunne, T.H.E., Sogaard, H. Liver biopsy in methotrexatetreated psoriatics — a re-evaluation. Acta Derm Venereol (Stockh), 1975, 55, 291–296.

    CAS  Google Scholar 

  15. Warin, A.P., Landells, J.W., Levene, G.M., et al. A prospective study of the effects of weekly oral methotrexate on liver biopsy. Br J Dermatol, 1975, 93, 321–327.

    CAS  PubMed  Google Scholar 

  16. Ashton, R.E., Millward-Sadler, G.H., White, J.E. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. J Invest Dermatol, 1982, 79, 229–232.

    Article  CAS  PubMed  Google Scholar 

  17. Tolman, K.G., Clegg, D.O., Lee, R.G., Ward, J.R. Methotrexate and the liver. J Rheumatol, 1985, 12 (Suppl 12): 29–34.

    Google Scholar 

  18. Aponte, J., Petrelli, M. Hepatic histology following prolonged treatment of rheumatoid arthritis with bolus methotrexate. Abstract Arthritis Rheum, 1985, 28, S37.

    Google Scholar 

  19. Geronemus, R.G., Auerbach, R., Tobia, H. Liver biopsies vs liver scans in methotrexate-treated patients with psoriasis. Arch Dermatol, 1982, 118, 649–651.

    Article  CAS  PubMed  Google Scholar 

  20. Lawrence, C.M., Strange, R.C., Summerly, R., et al. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy. Clin Chem Acta, 1983, 129, 341–351.

    Article  CAS  Google Scholar 

  21. Lenler-Petersen, P., Sogard, H., Thestrup-Pedersen, K., et al. Glactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis. Acta Dermatovener (Stockholm) 1982, 62, 448–449.

    CAS  Google Scholar 

  22. Rodnan, G.P., Schumacher, H.R. Primer on the Rheumatic Diseases, 8th Ed., Atlanta, Arthritis Foundation, 1983, 207–208.

    Google Scholar 

  23. Zachariae, H., Kragballe, K., Thestrup-Pedersen, R. et al. HLA antigens in methotrexate-induced liver cirrhosis. Acta Dermatol Venereol (Stockh), 1980, 60, 165–166.

    CAS  Google Scholar 

  24. Zachariae, H., Kragballe, K., Sogaard, H. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment. Br J Dermatol, 1980, 102, 407–412.

    CAS  PubMed  Google Scholar 

  25. Weinstein, G., Roenigk, M., Mailbach, M., Cosmides, J., Halprin, K., Millard, M. Cooperative Study, psoriasis-liver methotrexate interactions. Arch Dermatol, 1973, 108, 36–42.

    Google Scholar 

  26. Nyfors, A. Liver biopsies from psoriatic related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Microbiol Scand, 1977, Sect A, 85, 511–518.

    CAS  Google Scholar 

  27. Dahl, M.G., Gregory, M.M., Schever, P.J. Liver damague due to methotrexate in patients with psoriasis. Br Med J, 1971, 1, 625–630.

    CAS  PubMed  Google Scholar 

  28. Whaley, K., Webb, J. Liver and kidney disease in rheumatoid arthritis. Clin Rheum Dis, 1977, 3, 527–547.

    Google Scholar 

  29. Dahl, M.G., Gregory, M.M., Schew, P.J. Methotrexate hepatotoxicity in psoriasis. Comparison of different dose regimens. Br Med J, 1972, 1, 654–656.

    CAS  PubMed  Google Scholar 

  30. Roenigk, H.H., Jr., Auerbach, R., Maibach, H.I., et al. Methotrexate guidelines — revised. J Amer Acad Dermatol, 1982, 6, 145–155.

    Google Scholar 

  31. Nyfors, A., Poulsen, H. Liver biopsies from psoriasis related to methotrexate therapy. Findings before and after methotrexate therapy in 88 patients. A blind study. Acta Path Microbiol Scand, 1976, 84, 262–270.

    CAS  Google Scholar 

  32. Horvath, E., Saibil, F.G., Kovacs, K., et al. Fine structural changes in the liver of methotrexatetreated psoriatics. Digestion, 1978, 17, 488–502.

    CAS  PubMed  Google Scholar 

  33. Hoffmeister, R.T. Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med, 1983, 69–73.

  34. Kremer, J.L. A long-term prospective study of methotrexate in rheumatoid arthritis. Abstract, Arthritis Rheum, 1985, 28, S68.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Utah School of Medicine, 84132, Salt Lake City, Utah, USA

    P. A. Leonard, D. O. Clegg M.D., C. C. Carson, G. W. Cannon, M. J. Egger & J. R. Ward

Authors
  1. P. A. Leonard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. O. Clegg M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. C. Carson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. W. Cannon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. J. Egger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. R. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leonard, P.A., Clegg, D.O., Carson, C.C. et al. Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity. Clin Rheumatol 6, 575–582 (1987). https://doi.org/10.1007/BF02330596

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02330596

Key words

Search

Navigation